Daratumumab monotherapy in heavily pretreated Asians patients with relapsed and refractory multiple myeloma

被引:0
|
作者
Yoon, Sung-Soo [1 ]
Byun, Ja Min [1 ]
Park, Hyunkyung [2 ]
Lee, Ji Yun [3 ]
Koh, Youngil [1 ]
机构
[1] Seoul Natl Univ Hosp, Seoul, South Korea
[2] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词
Asia; daratumumab; real-world evidence;
D O I
10.1016/j.clml.2019.09.259
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
FP-174
引用
收藏
页码:E155 / E156
页数:2
相关论文
共 50 条
  • [41] Comparative Effectiveness of Daratumumab Monotherapy Versus a Real-World Historical Control from the Czech Republic in Heavily Pretreated and Highly Refractory Multiple Myeloma Patients
    Hajek, Roman
    Jelinek, Tomas
    Maisnar, Vladimir
    Pour, Ludek
    Spicka, Ivan
    Minarik, Jiri
    Gregora, Evzen
    Kessler, Petr
    Sykora, Michal
    Frankova, Hana
    Adamova, Dagmar
    Wrobel, Marek
    Mikula, Peter
    Jarkovsky, Jiri
    Gatopoulou, Xenia
    Vesela, Sarka
    Diels, Joris
    Besson, Herve
    Brozova, Lucie
    Ito, Tetsuro
    BLOOD, 2016, 128 (22)
  • [42] Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma
    Shackleton, Louisa
    Fay, James
    Smyth, Elizabeth
    Murphy, Philip
    Glavey, Siobhan
    Quinn, John
    EJHAEM, 2020, 1 (01): : 312 - 314
  • [43] DARATUMUMAB IN MONOTHERAPY AND COMBINATION AS TREATMENT IN RELAPSED / REFRACTORY MULTIPLE MYELOMA: EXPERIENCE OF A THIRD LEVEL HOSPITAL
    Auria Caballero, C.
    Gamarro Calvo, S.
    De Poo Rodriguez, M., V
    Martinez Fernandez, R.
    Sanchez Quinones, B.
    Dourdil Sahun, M., V
    Bonafonte Arruga, E.
    Alcacera Lopez, A.
    Palomera Bernal, L.
    HAEMATOLOGICA, 2018, 103 : 124 - 124
  • [44] Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma
    Usmani, Saad Z.
    Nahi, Hareth
    Mateos, Maria-Victoria
    van de Donk, Niels W. C. J.
    Chari, Ajai
    Kaufman, Jonathan L.
    Moreau, Philippe
    Oriol, Albert
    Plesner, Torben
    Benboubker, Lotfi
    Hellemans, Peter
    Masterson, Tara
    Clemens, Pamela L.
    Luo, Man
    Liu, Kevin
    San-Miguel, Jesus
    BLOOD, 2019, 134 (08) : 668 - 677
  • [45] Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma
    Hannah A. Blair
    Drugs, 2018, 78 : 397 - 397
  • [46] Real-world outcomes of daratumumab monotherapy in relapsed/refractory myeloma
    Maouche, N.
    Leary, H.
    Collings, F.
    Tseu, B.
    Djebbari, F.
    Vallance, G.
    Ramasamy, K.
    Kothari, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 125 - 125
  • [47] The efficacy and safety of daratumumab in relapsed and refractory multiple myeloma
    贾亚静
    China Medical Abstracts(Internal Medicine), 2020, 37 (03) : 189 - 189
  • [48] The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma
    Oriol, Albert
    Abril, Laura
    Torrent, Anna
    Ibarra, Gladys
    Ribera, Josep-Maria
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [49] Real-World Safety and Efficacy of Talquetamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma
    Shaikh, Hira
    Lochner, Jonathan
    Friend, Reed
    Snyder, Jordan
    Davis, James
    Patrus, Gina
    Dileo, Rachel
    Ahmed, Nausheen
    Mewawalla, Prerna
    Poonsombudlert, Kittika
    Struble, Emily
    Wolcott, Allyson
    Green, Kimberly
    Sparrow, Samantha
    Mushtaq, Muhammad Umair
    Paul, Barry
    Abdallah, Al-Ola
    Strouse, Christopher
    Hashmi, Hamza
    Atrash, Shebli
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S87 - S88
  • [50] Real-World Safety and Efficacy of Teclistamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma
    Dima, Danai
    Davis, James A.
    Ahmed, Nausheen
    Sannareddy, Aishwarya
    Shaikh, Hira
    Mahmoudjafari, Zahra
    Khouri, Jack
    Kaur, Gurbakhash
    Strouse, Christopher
    Valent, Jason
    Larry, Anderson D., Jr.
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD, 2023, 142